INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

4,771 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

Showing studies that examined broccoli. Clear

People assigned to a diet, food or program and measured.

16 studies

2020 / Unblinded controlled pilot trial

Broccoli sprout capsules did not significantly alter 180-day survival in pancreatic cancer

Forty patients receiving palliative chemotherapy were placed unblinded into a treatment group (n = 29, receiving 15 daily capsules of pulverized broccoli sprouts) or placebo group (n = 11, receiving methylcellulose) for up to 1 year. The mean death rate was lower in the treatment group in the first 6 months (day 30: 0% vs 18%, day 90: 0% vs 25%, day 180: 25% vs 43%), but the endpoint at day 180 was not statistically significant (p = 0.291). Dropout rates after 1 year were high (72% treatment, 55% placebo). Taking 15 daily capsules was difficult for some patients, and the sprouts sometimes increased digestive problems, nausea, and emesis.

Lozanovski VJ, Polychronidis G, Gross W, et al. Invest New Drugs, 2020. PMID 31250356

2018 / Randomized crossover trial

Eating broccoli with mashed potato reduced initial postprandial glucose and insulin responses.

In a randomized crossover trial with 13 healthy adults, adding two portions of cooked broccoli to mashed potato led to lower early postprandial blood glucose and insulin surges than potato alone. The broccoli-potato combination reduced peak glucose, incremental peak, and 30-minute incremental area under the curve for both markers. However, adding isolated broccoli fibre or cellulose did not alter post-meal curves compared with potato eaten by itself.

Ballance S, Knutsen SH, Fosvold ØW, et al. Eur J Nutr, 2018. PMID 27655525

2017 / Randomized controlled trial

Broccoli consumption leads to detectable isothiocyanates in human knee synovial fluid

In a randomized trial, 40 patients scheduled for total knee replacement consumed either a low or high glucosinolate diet for 14 days before surgery. Isothiocyanates and sulforaphane were detected in plasma and synovial fluid exclusively in the high glucosinolate group. Proteomic analysis of the synovial fluid revealed 125 differentially expressed proteins between the two diet groups.

Davidson R, Gardner S, Jupp O, et al. Sci Rep, 2017. PMID 28611391

2014 / Repeated measures crossover dietary intervention

A 10-day broccoli intervention increased folate and lutein and may reduce CRP levels in young male smokers.

In a repeated measures crossover study, young male smokers consumed 250 g/day of broccoli for 10 days. Broccoli intake significantly increased plasma levels of folate (+17%) and lutein (+39%), while no significant effect was observed for TNF-α, IL-6, IL-6sR, or adiponectin. Plasma CRP decreased by 48% (post-hoc analysis, p < 0.05) following the broccoli diet, independently of lutein and folate changes.

Riso P, Vendrame S, Del Bo' C, et al. Int J Food Sci Nutr, 2014. PMID 23992556

2014 / Clinical trial

Broccoli sprout extract decreased nasal total cell counts following diesel exhaust particle exposure.

Twenty-nine human subjects underwent an initial intranasal diesel exhaust particle challenge to assess inflammatory response. After a four-week washout, participants ingested broccoli sprout extract supplying 100 μmol sulforaphane daily for four days before undergoing a repeat particle challenge. Pretreatment with the extract decreased total cell counts in nasal lavage fluid by 54% (p < 0.001).

Heber D, Li Z, Garcia-Lloret M, et al. Food Funct, 2014. PMID 24287881

2014 / Randomized controlled trial

A polyphenol-rich food supplement slowed PSA progression in men with prostate cancer.

A randomized trial tested a capsule containing pomegranate, green tea, broccoli, and turmeric versus placebo for 6 months in 199 men with localized prostate cancer. The median increase in prostate-specific antigen was significantly lower in the supplement group at 14.7% (95% CI, 3.4-36.7%) compared to 78.5% in the placebo group (95% CI, 48.1-115.5%; P = 0.0008). Significantly fewer supplemented participants chose to exit surveillance (8.2% vs. 27.7%, P = 0.014).

Thomas R, Williams M, Sharma H, et al. Prostate Cancer Prostatic Dis, 2014. PMID 24614693

2014 / Randomized, double-blind, placebo-controlled trial

Broccoli sprout homogenate reduced nasal IL-6 and viral quantity in smokers, not nonsmokers.

Healthy young adult smokers and nonsmokers ingested broccoli sprout homogenate or alfalfa placebo for four days, receiving live attenuated influenza virus intranasally on the second day. In smokers, broccoli sprout ingestion significantly lowered post-inoculation nasal lavage IL-6 responses (P = 0.03) and influenza sequence quantity (P = 0.01), while raising quinone oxidoreductase. In nonsmokers, a similar downward trend in viral quantity did not achieve statistical significance.

Noah TL, Zhang H, Zhou H, et al. PLoS One, 2014. PMID 24910991

2014 / Randomized controlled trial

Broccoli sprout beverage increased excretion of airborne pollutant metabolites in a clinical trial.

In a 12-week randomized trial of 291 adults in China, drinking a daily broccoli sprout beverage significantly increased urinary excretion of glutathione conjugates of benzene by 61% and acrolein by 23% compared with placebo (P <= 0.01). Excretion of crotonaldehyde conjugates remained unchanged. Urinary sulforaphane metabolites showed that bioavailability was sustained throughout the 12-week daily dosing regimen.

Egner PA, Chen JG, Zarth AT, et al. Cancer Prev Res (Phila), 2014. PMID 24913818

2014 / Randomized clinical trial

Broccoli sprouts powder alone or with triple therapy eradicated H. pylori in many type 2 diabetes patients and improved some cardiovascular risk factors.

Eighty-six patients with type 2 diabetes and positive H. pylori stool antigen tests were randomized to standard triple therapy (STT) for 14 days, 6 g/d broccoli sprouts powder (BSP) for 28 days, or both (STT + BSP). H. pylori eradication rates were 89.3% in STT, 56.0% in BSP, and 91.7% in STT + BSP. Systolic and diastolic blood pressure significantly decreased in the STT + BSP group (P < 0.05), while serum triglycerides and TG/HDL-C ratio increased in the STT group (<0.05). In the BSP-only group, serum hs-CRP significantly decreased from 3.0 ± 2.5 at baseline to 2.3 ± 2.1 after treatment (P < 0.05).

Mirmiran P, Bahadoran Z, Golzarand M, et al. J Diabetes Metab Disord, 2014. PMID 24940565

2012 / Randomized double-blind clinical trial

Broccoli sprouts powder may improve insulin resistance in type 2 diabetic patients.

Eighty-one type 2 diabetic patients were randomly assigned to receive 10 g/d broccoli sprouts powder (BSP), 5 g/d BSP, or placebo for 4 weeks, with 63 included in the analysis. After 4 weeks, consumption of 10 g/d BSP resulted in a significant decrease in serum insulin concentration and HOMA-IR (p = 0.05 for treatment effect). Fasting serum glucose and glucose-to-insulin ratio were also measured. The authors concluded that broccoli sprouts may improve insulin resistance in type 2 diabetic patients.

Bahadoran Z, Tohidi M, Nazeri P, et al. Int J Food Sci Nutr, 2012. PMID 22537070

2012 / Quasi-experimental study

Offering salad dressing promoted raw broccoli consumption among bitter-sensitive preschoolers.

A 7-week study evaluated 152 predominantly Hispanic preschool children exposed twice weekly to raw broccoli served plain, with regular or light dip, or with sauce. Bitter taste sensitivity was present in 70% of the children. Among bitter-sensitive preschoolers, serving broccoli with dressing increased consumption by 80% compared to plain service (P < 0.001), while dip did not alter vegetable intake in bitter-insensitive children.

Fisher JO, Mennella JA, Hughes SO, et al. J Acad Nutr Diet, 2012. PMID 22741167

2011 / Crossover study

Bioavailability of sulforaphane and erucin was dramatically lower from a broccoli supplement than from fresh broccoli sprouts in human subjects.

In a crossover study, 12 subjects consumed 40 g of fresh broccoli sprouts followed by a 1-month washout, and then consumed 6 pills of a broccoli supplement (with 4 additional subjects serving as negative controls receiving alfalfa sprouts and placebo). Blood and urine were collected over 48 hours to measure sulforaphane and erucin metabolites. Bioavailability was dramatically lower, and peak plasma concentrations and urinary excretion were delayed, following the broccoli supplement compared to fresh broccoli sprouts. In vivo interconversion between sulforaphane and erucin occurred consistently within subjects but varied between subjects, while GSTP1 polymorphisms did not affect metabolism or excretion.

Clarke JD, Hsu A, Riedl K, et al. Pharmacol Res, 2011. PMID 21816223

2009 / Placebo-controlled dose escalation trial

Broccoli sprout sulforaphane increased antioxidant enzyme expression in the human upper airway

A placebo-controlled dose escalation trial evaluated oral sulforaphane from a standardized broccoli sprout homogenate in human subjects. Dosing safely produced dose-dependent increases in upper airway nasal lavage cell RNA expression for GSTM1, GSTP1, NQO1, and HO-1, peaking at the 200 g sprout dose. In contrast, ingestion of control alfalfa sprouts lacking sulforaphane failed to stimulate Phase II enzyme induction.

Riedl MA, Saxon A, Diaz-Sanchez D Clin Immunol, 2009. PMID 19028145

2008 / Randomized crossover trial

Raw broccoli produced faster absorption and higher sulforaphane bioavailability than cooked broccoli.

Eight men consumed 200 g of crushed raw or cooked broccoli with a warm meal in an open crossover study. Sulforaphane bioavailability reached 37% after raw broccoli versus 3.4% following cooked broccoli (p = 0.002). Time to peak plasma levels was shorter for raw (1.6 h) than cooked broccoli (6 h, p = 0.001), while excretion half-lives remained comparable.

Vermeulen M, Klöpping-Ketelaars IW, van den Berg R, et al. J Agric Food Chem, 2008. PMID 18950181

2004 / Clinical trial

Broccoli sprouts were linked to Helicobacter pylori eradication in some patients

Nine patients with Helicobacter pylori infection consumed broccoli sprouts twice daily for seven days. Stool antigen tests were negative in seven of nine participants immediately post-treatment and in six at day 35. Eradication of the infection was temporally linked to sprout intake in three of nine patients, and most found the food palatable.

Galan MV, Kishan AA, Silverman AL Dig Dis Sci, 2004. PMID 15387326

1999 / Incomplete block design trial

Vegetable types and physical disruption altered plasma lutein, folate, and beta-carotene bioavailability.

Sixty-nine volunteers consumed four-day vegetable or beta-carotene-supplemented meals. Broccoli and green peas increased plasma beta-carotene by 28% (95% CI: 6.4, 55) and 26% (95% CI: 2.6, 54), while spinach had no effect despite higher content. All vegetables increased lutein and vitamin C. Disrupting the spinach matrix enhanced plasma lutein by 14% (95% CI: 3.7, 25) and folate by 10% (95% CI: 2.2, 18).

van het Hof KH, Tijburg LB, Pietrzik K, et al. Br J Nutr, 1999. PMID 10655967